Zhou Ying, Fan Qianqian, Cavus Omer, Zhang Xuezheng
Department of Anesthesiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Saudi J Anaesth. 2018 Jul-Sep;12(3):457-461. doi: 10.4103/sja.SJA_73_18.
The purpose of the study was to review and summarize current literature concerning the validation and application of lung ultrasound (LUS) in critically ill patients with acute respiratory distress syndrome (ARDS).
An extensive literature search was conducted using PubMed, Cochrane Review, Google Scholar, and Ohio State University Link based on the question if LUS should be considered a reliable investigational technique for ARDS diagnosis, treatment, and prognosis in pediatric and adult population.
LUS has been successfully validated for facilitating early diagnosis and diagnosis of simultaneous lung conditions, predicting lung recruitment treatment effect, and evaluating the prognosis in ARDS patients. Whether lung US is a useful tool in the prediction of prone position and oxygenation response in patients with ARDS is conflicting.
LUS is a noninvasive, radiation-free, cheap, and easy to perform tool for critically ill patients with ARDS and might be a promising technique used in the Intensive Care Unit for ARDS management.
本研究的目的是回顾和总结当前关于肺超声(LUS)在急性呼吸窘迫综合征(ARDS)危重症患者中的验证和应用的文献。
基于LUS是否应被视为儿科和成人人群中ARDS诊断、治疗和预后的可靠研究技术这一问题,使用PubMed、Cochrane综述、谷歌学术和俄亥俄州立大学链接进行了广泛的文献检索。
LUS已成功验证可用于促进ARDS患者的早期诊断和同时存在的肺部疾病的诊断、预测肺复张治疗效果以及评估预后。肺超声在预测ARDS患者俯卧位和氧合反应方面是否有用存在争议。
LUS是一种用于ARDS危重症患者的无创、无辐射、廉价且易于操作的工具,可能是重症监护病房用于ARDS管理的一种有前景的技术。